|
WAKEFIELD, Mass., 30 Nov. 2005. Implant Sciences Corp. today announced the award of a $338,000 contract from the U.S. Navy to design a portable explosives detector which will integrate features of the company's Quantum Sniffer handheld and desktop detectors into a combined handheld and backpack device.
This design will provide the Navy with a more portable explosives detector which can be used in more confined areas while providing the operator/inspector increased mobility and use of hands. Delivery of this newly designed portable explosives detector is scheduled within the next eight months.
Quantum Sniffer technology differs from competing approaches because the company's products detect a wide array of explosives, including PETN, which is the elusive active component of Semtex, using a proprietary non-contact sampling system. The equipment does not require radioactive sources or consumables, as is required by competitive products.
"The U.S. Navy and Implant Sciences have been working cooperatively over the past several years to take our Quantum Sniffer technology from a concept to a commercial product. This new contract should enable us to configure our currently available products into a new device that should meet the Navy's design requirements for explosives detection," said Anthony J. Armini, PhD., the CEO of Implant Sciences.
"We believe the Quantum Sniffer technology, which has been clearly differentiated from competitive technologies and products, is well suited for the applications requested by the Navy and should result in a device that provides the operator greater flexibility and efficiency in carrying out the task of inspecting vessels, vehicles and military installations for the presence of explosive materials. We are pleased with the Navy's decision to have us design equipment which specifically fits their special needs using Implant's Quantum Sniffer technology."
Implant Sciences, incorporated in 1984, is using its core ion technology to develop, manufacture and market products for the homeland security, semiconductor and medical device industries. The company has developed and commercialized portable and bench-top detection devices to identify explosives which are distributed under the Quantum Sniffer brand name.
The company also provides state of the art ion implantation and wafer analytical services for the semiconductor industry. The company also develops, manufactures and sells radioactive products for the treatment of cancer, including sales of radioactive seeds for the treatment of prostate cancer and development of a new, FDA approved radioactive source for use in the treatment of breast cancer. For more information, see www.implantsciences.com.
| 
Community 
| View all PennWell sites | View all PennWell events
Add RSS Feed